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Abstract
This study uses dosimetry film measurements and Monte Carlo simula-
tions to investigate the accuracy of type-a (pencil-beam) dose calculations
for predicting the radiation doses delivered during stereotactic radiotherapy
treatments of the brain. It is shown that when evaluating doses in a water
phantom, the type-a algorithm provides dose predictions which are accurate
to within clinically relevant criteria, γ(3%,3mm), but these predictions are
nonetheless subtly different from the results of evaluating doses from the same
fields using radiochromic film and Monte Carlo simulations. An analysis of
a clinical meningioma treatment suggests that when predicting stereotactic
radiotherapy doses to the brain, the inaccuracies of the type-a algorithm can
be exacerbated by inadequate evaluation of the effects of nearby bone or air,
resulting in dose differences of up to 10% for individual fields. The results of
this study indicate the possible advantage of using Monte Carlo calculations,
as well as measurements with high-spatial resolution media, to verify type-a
predictions of dose delivered in cranial treatments.
Keywords: computer simulation, dosimetry, pencil beam, radiochromic
film, stereotactic radiosurgery
1. Introduction
Cancerous and benign lesions of the brain can be treated with radiother-
apy, by using very small (stereotactic) radiation fields. Because the brain is
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composed of tissues with a nearly uniform density and does not contain any
substantial volumes of either air or bone, the use of a pencil-beam single-
convolution algorithm that does not account for changes to electron trans-
port caused by density heterogeneities (designated ‘type-a’ by Knoos et al.
(2006)) seems to be an efficient means to perform accurate treatment plan-
ning calculations for cranial cases. Type-a treatment planning calculations
of small-field radiation doses delivered to tumors in more heterogeneous tis-
sues (most obviously the lungs (Knoos et al., 1995) but also the head and
neck (Seco et al., 2005; Partridge et al., 2006)) are known to have limited
accuracy. For stereotactic fields, the accuracy of treatment planning dosime-
try is difficult to verify by standard measurement alone due to the physical
limitations of the measuring devices available (Das et al., 2008). There is
therefore an obvious advantage to being able to verify the planned dosimetry
of stereotactic treatments using continuous dosimetry media such as gels and
films (Kairn et al., 2010c) in conjunction with an established Monte Carlo
code, such as BEAMnrc (Rogers et al., 1995).
This study uses radiochromic film measurements and Monte Carlo dose
calculations to test the assumption that a type-a radiotherapy treatment
planning algorithm is sufficient to predict the dosimetry of small-field ra-
diotherapy treatments in the brain. Here, the accuracy of type-a dose pre-
dictions made using Version 3.0.2 of the iPlan treatment planning system
(Brainlab, Feldkirchen, Germany) are evaluated, for sample stereotactic ra-
diotherapy treatments delivered to a planar solid water phantom and to het-
erogeneous human tissue using the Brainlab m3 micro-multileaf collimator
(Brainlab, Feldkirchen, Germany) (Cosgrove et al., 1999).
2. Methods
The dose predictions made by iPlan’s type-a (pencil-beam) dose calcula-
tion algorithm were compared with (a) radiochromic film measurements and
the results of Monte Carlo simulations of a treatment delivered to solid water
and (b) Monte Carlo simulations of a hypothetical treatment to a stereotactic
radiotherapy patient. Using iPlan, a sample treatment plan for an arteriove-
nous malformation treatment, which had an average field width of 1.5 cm and
a minimum field width of 0.2 cm (measured at the isocenter), was mapped
onto a computed tomography (CT) scan of a Virtual Water phantom (Stan-
dard Imaging, Middleton, USA) and recalculated, with gantry angles and
couch angles set to zero (according to local quality assurance protocol). This
2
treatment plan, including dose grids, was exported for delivery to film and
for comparison with Monte Carlo calculations. A nine field conformal treat-
ment plan for a meningioma treatment, which had an average field width of
2.5 cm and a minimum field width of 0.2 cm (measured at the isocenter),
was directly exported from iPlan (including patient CT data, calculated dose
grids and regions of interest) in DICOM format, for comparison with Monte
Carlo simulations.
The radiochromic film images were obtained using eight sheets of Gafchromic
EBT2 dosimetry film (International Specialty Products, Wayne, USA). The
film sheets were cut and pre-scanned using an Epson Perfection V700 Photo
flatbed scanner (Seiko Epson Corp., Nagano, Japan) as recommended by
Kairn et al. (2010b). For irradiation, each film was placed within the block
of Virtual Water used in iPlan’s recalculated treatment plan. Each film was
irradiated using a different field from the arteriovenous malformation treat-
ment, with all beams delivered from a zero gantry angle. Irradiations were
performed using a Varian Clinac iX linear accelerator (Varian Medical Sys-
tems, Palo Alto, USA), producing a nominal 6 MV photon beam, with the
120-leaves of its Millennium MLC fully retracted (to ±20.08 cm, projected
to the isocenter) and the BrainLAB m3 micro-multileaf collimator (µMLC)
attached at its exit. After waiting 24 hours from the time of irradiation, the
films were re-scanned and their optical densities converted to two-dimensional
maps of absorbed dose (Kairn et al., 2010b).
The Varian linear accelerator and BrainLAB m3 µMLC used in this study
were modeled as previously described (Kairn et al., 2010c,a,d) using the
BEAMnrc and DOSXYZnrc Monte Carlo code, with corrections for output
deviations due to collimator backscatter into the monitor chamber based
on previous work (Kairn et al., 2009). This study relied on the use of the
MCDTK package (Crowe et al., 2009): to convert the DICOM-format treat-
ment plans obtained from iPlan into BEAMnrc and DOSXYZnrc input files
with the correct jaw and µMLC positions; to convert the CT images of the
Virtual Water and meningioma patient into a voxelised text format suitable
for use with DOSXYZnrc; and to generate isodoses, two-dimensional dose
maps, dose profiles and dose-volume histograms for the patient treatment,
to allow quantitative comparisons between the Monte Carlo and iPlan results.
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3. Results
3.1. Water phantom treatment
Figure 1(a) typifies the dose profiles measured using radiochromic film
and calculated using the accurate Monte Carlo model and the type-a treat-
ment planning algorithm, for fields delivered to Virtual Water. Like Fig-
ure 1(a), results for all eight beams used in this part of the study showed
that: there is agreement between film measurements and Monte Carlo cal-
culations to within strict acceptance criteria, γ(2%,1mm); there are details
in profiles from both the Monte Carlo calculations and the film measure-
ments, which are not apparent in the type-a predictions (for example, see
the feature -1.0 cm from the central axis in Figure 1(a)); the film and the
Monte Carlo calculations show that the beams have narrower penumbrae
than the type-a algorithm predicts; and the doses at the centers of the fields
obtained from film measurements and Monte Carlo simulations differ by up
to 3% from the doses predicted using the type-a algorithm. Importantly,
the film measurements and Monte Carlo calculations for all fields consis-
tently agree with the type-a predictions within clinically relevant acceptance
criteria, γ(3%,3mm), and certainly within internationally recommended ac-
ceptance criteria, γ(5%,5mm) (ICRU, 2010). It can be concluded that when
used to predict the doses delivered by small fields to a planar, homogenous
block of Virtual Water, the type-a algorithm provides a degree of accuracy
that is acceptable for clinical use, although its dose predictions are subtly
but measurably different from doses obtained from both dosimetry film and
Monte Carlo simulations.
3.2. Meningioma patient treatment
When used to evaluate the doses delivered by a hypothetical treatment
to a meningioma patient, the type-a algorithm produces more substantial
inaccuracies. In the profiles through the isocenter of this patient treatment,
an example of which is shown in Figure 1(b), the Monte Carlo calculations
show narrower and steeper penumbrae than the pencil beam predicts, which
is similar to the results discussed above, for the water phantom, and which
may be due to slight inaccuracies in the micro-ion chamber measurements
that were used to commission the iPlan treatment planning system. Monte
Carlo dose calculations at the treatment isocenter for each beam range from
from 3% below to 10% above the type-a predictions, with the larger differ-
ences being apparent in the profiles for beams that have passed though bone
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Figure 1: Dose profiles in (a) a water phantom and (b) heterogeneous patient tissue,
for dose calculated using the type-a algorithm (heavy grey line) and the Monte Carlo
simulations (fine black line) as well as, for figure (a), dose measured using radiographic
film (fine, dotted line). The inset in figure (b) shows the location of the radiation field
and the plotted profile (vertical white line) in relation to patient anatomy (compare with
CT images in figure 2).
Figure 2: Patient CT image overlaid with isodoses lines derived from (a) the iPlan type-a
dose predictions and (b) a Monte Carlo simulation of the treatment. (Note that in the
Monte Carlo data, dose to the air outside the patient is not automatically set to zero as
it is in the type-a data.)
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or air cavities. The profiles shown in Figure 1(b) were generated at the sphe-
noid bone, for a beam that had traversed almost the entire cranial cavity,
partially intersecting the paranasal sinuses. Consequently, the data shown in
Figure 1(b) show obvious disagreement and represent a worst-case-scenario
for this treatment.
Despite the clear disparity that is apparent when individual beam profiles
were compared, the overall result of calculating the dose for the entire treat-
ment using the Monte Carlo model and the type-a algorithm show relatively
good agreement. Figures 2(a) and (b) show sets of isodose lines obtained from
three dimensional dose grids produced by the type-a algorithm and from a
Monte Carlo simulation of the treatment. Both sets of isodoses indicate that
the tumor is covered by the prescription dose, although there are noticeable
deviations in the volumes of tissue within lower isodoses, especially in regions
close to bone.
Figure 3: Cumulative dose-volume distograms, plotted using data calculated using the
type-a algorithm (heavy, grey lines) and the Monte Carlo model (fine, black lines), for (a)
the tumour, (b) the brain stem, (c) the optic nerve and (d) the optic chiasm.)
Examination of the cumulative dose-volume histogram (DVH) data il-
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lustrated in Figures 3(a) and (b) shows that the type-a calculations for the
different beams combine to produce a relatively accurate prediction of the
overall doses to both the tumor and the brain stem. Examination of DVH
data for other critical structures, exemplified in Figures 3(c) and (d), show
that the type-a algorithm has underestimated the volumes of these tissues
that would receive radiation doses of up to 40 Gy, if this treatment was
delivered to the patient. The clinical relevance if these differences can be
elucidated through examination of the data in Table 1.
Table 1 lists the maximum doses as well as the doses received by 90%
and 50% of the volumes of the tumor, brain stem, optic nerve and optic chi-
asm, as calculated using the type-a algorithm and Monte Carlo simulations.
Like the DVH data (from which they were derived) the values in Table 1
show good agreement in the doses calculated for the tumor and brain stem,
with poorer agreement between the doses calculated for the optic nerve and
optic chiasm. It should be noted, however, that all doses to critical struc-
tures calculated using both methods are below levels linked to a 3-5% of
necrosis or neuropathy (Marks et al., 2010). For this patient, all doses to
the tumor and critical structures evaluated using the both type-a and Monte
Carlo calculations conform to the original treatment planning objectives and
constraints.
Table 1: Doses (in Gy) calculated in the tumour and critical structures, using the type-a
algorithm and the Monte Carlo model.
Region D(V=90%) D(V=50%) Dmax
Type-a MC Type-a MC Type-a MC
Tumour 50.8 50.5 54.3 54.2 62.2 62.9
Brain stem 3.3 3.3 16.2 16.6 44.8 44.8
Optic nerve 21.2 21.4 31.7 32.3 38.6 40.4
Optic chiasm 11.2 11.0 18.8 21.4 38.4 37.1
4. Conclusion
When evaluated in comparison to Monte Carlo simulations and radiochromic
film measurements, type-a predictions of the doses delivered by very small
fields can be measurably inaccurate, even when these doses are evaluated
in water. When predicting stereotactic radiotherapy doses to the brain, the
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inaccuracies of the type-a algorithm can be exacerbated by inadequate eval-
uation of the effects of nearby bone or air.
Although the patient treatment examined here conformed to treatment
planning objectives and constraints, the results of this study indicate the
possible advantage of using Monte Carlo calculations to verify type-a pre-
dictions of dose delivered in cranial treatments in addition to treatments
delivered to more heterogeneous regions, such as lung. Measurements made
using a medium with a high spatial resolution, such as dosimetric film, can
also be used to test and verify the predictions made using type-a algorithms,
such as that used by the iPlan stereotactic radiotherapy treatment planning
system.
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